Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kristopher Sanders

Orthopaedic Surgery Chattanooga, TN Medical Doctor

NPI 1730405531 CMS profile 2170424

979 E 3Rd St, Suite C-430, Chattanooga, TN 37403

Open in the dashboard

General payments

$8,323

97 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kristopher Sanders of Chattanooga, TN is reported in the CMS Open Payments database as having received $8,323 across 97 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,186 30
2024 General $276 8
2023 General $266 12
2022 General $2,637 16
2021 General $979 13
2020 General $147 3
2019 General $831 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kristopher Sanders
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Kristopher Sanders were reported at $3,186. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Kristopher Sanders Orthopaedic Surgery median Middle half National median
2019 $831 $644 $140–$2,844 $163
2020 $147 $312 $75–$1,860 $114
2021 $979 $520 $117–$2,495 $132
2022 $2,637 $598 $128–$2,731 $149
2023 $266 $461 $128–$2,264 $160
2024 $276 $497 $134–$2,475 $164
2025 $3,186 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $4,102 34 payments
  2. Smith+Nephew, Inc. $3,061 25 payments
  3. Alpha Orthopedic Systems $198 2 payments
  4. Ferring Pharmaceuticals Inc. $175 12 payments
  5. Encore Medical, LP $173 2 payments
  6. Smoky Mountain Surgical LLC $121 3 payments
  7. DePuy Synthes Sales Inc. $116 1 payment
  8. Heron Therapeutics, Inc. $45 2 payments
  9. Medical Device Business Services, Inc. $32 1 payment
  10. Zimmer Biomet Holdings, Inc. $28 1 payment
  11. Other $270 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $4,301 12 payments
  2. Food and Beverage $4,022 85 payments
Products named General payments · program years 2019–2025
  1. MAKO $2,366 12 payments
  2. REAL INTELLIGENCE $1,836 7 payments
  3. JOURNEY II $1,720 5 payments
  4. JOURNEY $1,612 4 payments
  5. RI Hip Navigation $1,612 4 payments
  6. TRIATHLON $668 5 payments
  7. POLARSTEM $668 1 payment
  8. MAKOPLASTY $341 8 payments
  9. EUFLEXXA $175 12 payments
  10. DJO SURGICAL $150 1 payment
  11. Other $2,045 48 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

726

Median for Orthopedic Surgery: 203

Drug cost

$5,521

Median for Orthopedic Surgery: $1,433

Branded share of claims

19.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 32 $824
Ibuprofen Generic 98 $786
Ondansetron Odt Ondansetron Brand 109 $709
Diclofenac Sodium Generic 12 $607
Methocarbamol Generic 73 $591
Cefadroxil Generic 90 $579
Pregabalin Generic 37 $418
Oxycodone Hcl Generic 58 $404
Tramadol Hcl Generic 88 $296
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 19 $128

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$207,798

Of which drugs: $1,032

Medicare patients

420

Average age 72

Services billed

3,252

259 women, 161 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 25%
Ischemic heart disease 25%
Depression 25%
Chronic kidney disease 24%
Osteoporosis 18%
Atrial fibrillation 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 23 2,001 $192
Injection, methylprednisolone acetate, 80 mg J1040 Office 20 24 $122

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

97 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record